Yta Labs

Find Your Peptide Targets Now

Leverage our unique identification platform to speed up your discovery process

Transform your
target discovery

Our best-in-class technology selects the best pMHC targets from the haystack of candidates in typical mass spectrometry-based workflows. This means less time spent validating low quality targets, and more time focusing on developing treatments that work.

70%

Fewer assays per target

15x

Faster timelines from patient samples to validated targets

3x

More candidates per sample

Improve Your Discovery Pipeline

Improved Selection

Leveraging both sequence and structure data from target candidates, our deep learning-driven workflow recovers more quality targets

Increased Velocity

With up to 70% reduced assay requirements to identify as many viable targets

Accurate Results

Recover the peptide targets that other methods miss

Request platform access